Special Chief Secretary in Telangana, Arvind Kumar, has been summoned by the Anti-Corruption Bureau (ACB) on July 1 in ...

Kymera Therapeutics, Inc.'s stock rose on KT-621 data, but Sanofi's exit casts doubts. A Gilead Sciences, Inc. deal offers ...

Kymera on Wednesday said Sanofi won't advance KT-474, which in late 2023 entered Phase 2 studies trials in patients with the inflammatory skin diseases hidradenitis suppurativa and atopic dermatitis.

Vedanta Resources posts $18.2B revenue & $5.5B EBITDA for FY25, marking significant growth amidst global economic shifts.

The countdown is on for one of the UAE’s most exciting new recognitions of talent — the KT Plus 150 list. The initiative, to ...

Publsh Media joins Brand ME Summit 2025 in Dubai, enhancing personal branding and strategic connections for 6,000+ attendees.

Dan Zarrow is Chief Meteorologist for Townsquare Media New Jersey. The Shore Report is generated semi-automatically daily at ...

Vedanta Resources Limited, world’s leading transition metals, critical minerals, energy and technology company, delivered ...

This comes days after former minister and BRS working president KT Rama Rao was interrogated by the ACB for almost eight hours on 16 June.

Catch up with the most important stories from around Europe and beyond - latest news, breaking news, World, Business, ...

After nine years operating a food tent, and four years operating a food truck, restaurateurs Terry and Kenwin Chiddick will ...

Kymera Therapeutics is celebrating the signing of two partnerships, with Gilead Sciences taking an option on one molecular ...